Hormone therapy after risk-reducing surgery in patients with BRCA1/BRCA2 mutation: evaluation of potential benefits and safety

SUMMARY Women with mutations in the BRCA 1 and 2 genes are at increased risk for ovarian and breast cancer and therefore candidates for risk-reducing surgery, including salpingo-oophorectomy and mastectomy. Risk-reducing salpingo-oophorectomy (RRSO) is considered the most effective prophylactic meas...

ver descrição completa

Detalhes bibliográficos
Autor principal: Silva Filho,Agnaldo Lopes da (author)
Outros Autores: Carvalho,Gabriella Martins (author), Sena,Larissa Cristelli de (author), Gomes,Lívia Passini Guimarães (author), Valério,Marcos Flávio Habib (author), Martins,Raíssa Isabelle Leão (author), Cândido,Eduardo Batista (author)
Formato: article
Idioma:eng
Publicado em: 2020
Assuntos:
Mutation
Estrogen replacement therapy
Salpingostomy
Ovariectomy
Salpingo-oophorectomy
Breast neoplasms
Ovarian neoplasms
Texto completo:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302020000801134
País:Brasil
Oai:oai:scielo:S0104-42302020000801134

Texto Completo

http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302020000801134

Registos relacionados